Amrize Ltd (NYSE:AMRZ) Stock Has Average Price Target of $47.65 According to Brokerages

Key Points

• Analysts’ consensus is “Hold”: Among 19 analysts, eight rate Amrize a buy, seven a hold, and four a sell; the average 12-month price target is $47.65.
• Amrize reported quarterly EPS of $1.05, matching estimates, on $3.77 billion in revenue, up 2.6% year over year.
• The company declared a dividend of $0.11 per share, and insiders purchased a combined 34,155 shares worth about $1.46 million in the last quarter.

Shares of Amrize Ltd (NYSE:AMRZ - Get Free Report) have been given an average recommendation of "Hold" by the nineteen analysts that are covering the company, Marketbeat reports. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $47.65.

Several analysts have recently issued reports on the company. William Blair set a $40.00 target price on Amrize in a report on Wednesday, September 2nd. Zacks Research downgraded Amrize from a "hold" rating to a "strong sell" rating in a research note on Wednesday, August 19th. Sanford C. Bernstein reaffirmed an "outperform" rating and set a $60.00 price objective on shares of Amrize in a research report on Monday, September 21st. Stephens cut their price objective on shares of Amrize from $65.00 to $54.00 and set an "overweight" rating for the company in a research report on Wednesday, August 12th. Finally, Citigroup reduced their price objective on shares of Amrize from $58.00 to $50.00 and set a "buy" rating on the stock in a research note on Friday, October 2nd.

Amrize Trading Down 2.0%

Shares of NYSE:AMRZ opened at $41.96 on Wednesday. The business's 50 day simple moving average is $39.46 and its 200 day simple moving average is $50.18. Amrize has a 1 year low of $35.78 and a 1 year high of $65.94. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.67. The company has a market capitalization of $23.21 billion, a P/E ratio of 18.99, a P/E/G ratio of 1.68 and a beta of 0.04.

Amrize (NYSE:AMRZ - Get Free Report) last announced its quarterly earnings data on Wednesday, October 28th. The company reported $1.05 earnings per share for the quarter, meeting the consensus estimate of $1.05. The firm had revenue of $3.77 billion during the quarter. Amrize had a return on equity of 10.02% and a net margin of 9.93%. Amrize's revenue was up 2.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.98 earnings per share. On average, research analysts anticipate that Amrize will post 2.30 EPS for the current fiscal year.

Amrize Announces Dividend

The company also recently declared a dividend, which will be paid on Wednesday, November 18th. Stockholders of record on Tuesday, November 10th will be issued a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, November 10th. Amrize's dividend payout ratio is 4.98%.

Insider Activity at Amrize

In other news, Director Jacques Sanche purchased 4,150 shares of Amrize stock in a transaction that occurred on Wednesday, August 26th. The shares were acquired at an average price of $45.02 per share, for a total transaction of $186,833.00. Following the transaction, the director owned 9,766 shares of the company's stock, valued at approximately $439,665.32. The trade was a 73.90% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Jan Jenisch acquired 4,000 shares of the firm's stock in a transaction that occurred on Wednesday, September 2nd. The stock was purchased at an average cost of $42.50 per share, for a total transaction of $170,000.00. Following the completion of the purchase, the chief executive officer directly owned 519,000 shares of the company's stock, valued at $22,057,500. The trade was a 0.78% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased a total of 34,155 shares of company stock worth $1,461,276 in the last quarter. 0.54% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Amrize

Hedge funds and other institutional investors have recently modified their holdings of the business. Continuum Advisory LLC acquired a new position in shares of Amrize during the 2nd quarter worth $62,000. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Amrize in the third quarter valued at about $49,000. IFP Advisors Inc boosted its stake in Amrize by 1,707.3% in the third quarter. IFP Advisors Inc now owns 1,988 shares of the company's stock valued at $74,000 after buying an additional 1,878 shares in the last quarter. NewEdge Advisors LLC grew its position in Amrize by 1,419.7% in the second quarter. NewEdge Advisors LLC now owns 2,082 shares of the company's stock valued at $111,000 after acquiring an additional 1,945 shares during the last quarter. Finally, Oslo Pensjonsforsikring AS bought a new position in Amrize in the first quarter valued at about $133,000.

About Amrize

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets. The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects. Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim's North American business.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.